Concepedia

Publication | Open Access

Reduced Expression of Metastasis Suppressor RhoGDI2 Is Associated with Decreased Survival for Patients with Bladder Cancer

DOIFull Paper Access

163

Citations

16

References

2004

Year

Dan Theodorescu, Lisa M. Sapinoso, Mark R. Conaway, Gary Oxford, Garret M. Hampton, Henry F. Frierson
Clinical Cancer Research

Abstract

These results suggest that RhoGDI2 is an independent predictor of prognosis for patients with bladder cancer and provide clinical evidence in support of its involvement in cancer metastasis.

References

YearCitations

Page 1